SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem recalls 368 bottles of Lamotrigine tablets in US

06 Oct 2016 Evaluate

Unichem Laboratories is recalling 368 bottles of Lamotrigine tablets, used for treating epilepsy and bipolar disorder, in the US due to incorrect imprint debossed on the tablets. The company has initiated the recall on August 19 this year.

The recall has been initiated by the company’s US arm Unichem Pharmaceuticals Inc covering 368 bottles of Lamotrigine tablets USP in strength of 150 mg. The tablets have been manufactured at the company’s Goa facility. A single bottle contains 500 tablets of the medicine.

The recall is a ‘Class III recall’ and as per the US Food and Drug Administration (USFDA), a Class III recall is initiated in a situation, in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.



Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×